Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-30
1999-01-19
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514571, 514350, 514312, 514423, 514539, 514616, 549 62, 562463, 546299, 546156, 548533, 548537, 560 9, 560 17, 560 35, 560 39, A61K 3138, A61K 3119, A61K 3144, A61K 3124
Patent
active
058614281
ABSTRACT:
Inhibitors for matrix metalloproteases, pharmaueutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula ##STR1## wherein each Tis a substituent group; x is 0, 1, or 2; the group D represents ##STR2## the group R6 reresents a variety of possible substituent groups on the carbon chain between D and G, and the group G represents M, ##STR3## in which M represents --CO.sub.2 H, --CON(R.sup.11).sub.2, or --CO.sub.2 R.sup.12, and R.sup.13 represents any of the side chains of the 19 noncyclic naturally occurring amino acids.
REFERENCES:
patent: 3182061 (1965-05-01), Goldschmidt
patent: 3749750 (1973-07-01), Wei
patent: 3784701 (1974-01-01), Tomcufcik et al.
patent: 3962228 (1976-06-01), Wei et al.
patent: 3997589 (1976-12-01), Seeger et al.
patent: 4021479 (1977-05-01), Seeger et al.
patent: 4219668 (1980-08-01), Chiccarelli
patent: 4247466 (1981-01-01), Chiccarelli
patent: 4472316 (1984-09-01), Sota et al.
patent: 4683331 (1987-07-01), Kuchar et al.
patent: 5177204 (1993-01-01), Kuchar et al.
Chiccarelli et al., "Disposition and Metabolism of Fenbufen in several Laboratory Animals", Arzneim.-Forsch./Drug Res., 30(I), 707-715 (1980).
Child et al., "A New Non-steroidal Anti-inflammatory Analgesic: .gamma.-Oxo (1,1'-biphenyl)-4-butanoic Acid (Fenbufen)", Arzneim.-Forsch./Drug Res., 30(I), 695-702 (1980).
Child et al., "Fenbufen, a New Anti-Inflammatory Analgesic: Synthesis and Structure-Activity Relationships of Analogs", J. Pharma. Sci., 66(4), 466-476 (1977).
Cousse et al., "Synthese, structure et activite hypocholesterolemiante d'une serie d'acides .gamma.-aryl, .+-.-oxo butyriques substitues et derives", Eur. J. Med. Chem., 22, 45-57 (1987).
Curran, W. V. and Ross, A., "6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. A Series of Hypotensive Agents", J. Med. Chem., 17(3), 273-281 (1974).
Farbenind, I. G., "Compounds having capillary action", Chem. Abstracts, 30, 7729.sup.3 (1936).
Kameo et al., "Studies on Antirheumatic Agents: 3-Benzoylpropionic Acid Derivatives", Chem. Pharm. Bull., 36(6), 2050-2060 (1988).
Kawashima et al., "Structure-Activity Studies of 3-Benzoylpropionic Acid Derivatives Suppressing Adjuvant Arthritis", Chem. Pharm. Bull., 40(3), 774-777 (1992).
Tomisawa et al., "Studies on Hypolipidemic Agents. II. 3-(4-Phenoxybenzoyl)-propionic Acid Derivatives", Chem. Pharm. Bull., 33(6), 2386-2394 (1985).
Weizmann et al., "A New Method for the Synthesis of .beta.-Phenyl-Naphthalene Derivatives", Chemistry and Industry, pp. 402-404, Jun. 8, 1940.
Sammour et al., "Alkylation of Aromatic Hydrocarbons with .beta.-Aroylacrylic Acids", J. Prakt.Chemie, 314, 5-6, 906-914(1972).
El-Hashash et al., "Reactions of 3,5-Disubstituted-2-Furanone with Amines, Grignard Reagents, Toluene and Xylene", Indian Journal of Heterocyclic Chemistry, 5, 231-232 (1996). benzoyl! propionic Acids Derivatives", Chem.Pharm. Bull., 37(5), 1260-1267 (1989).
Takeshita et al., "Immunopharmacological Studies of New 3-Benzoyl-4-Mercaptobutyric Acid Derivatives. II Immunosuppressive Effects", Drugs Exptl.Clin.Res., XIV(5), 311-318 (1988).
Fournel et al., "Differential induction profile of drug-metabolizing enzimes after treatment with hypolipidemic agents", Xenobiotica, 17(4), 445-457 (1987).
Kuchar et al., "Quantitative Relations Between Structure and Anti-Inflammatory Activity of Ayloxoalkanoic Acids", Collection Czechoslovak Chem.Commun., 53, 1862-1872 (1988).
Chem.Abstr. Accession No. 108: 31304. Kuchar, et al., Metabolic Model and QSAR of Long-acting Anti-inflammatory Arylaliphatic Acids, (1988).
Dixon Brian Richard
Kluender Harold Clinton Eugene
VanZandt Michael Christopher
Wilhelm Scott McClelland
Wolanin Donald John
Bayer Corporation
Lambkin Deborah C.
LandOfFree
Substituted 4-biarylbutyric acid derivatives as matrix metallopr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 4-biarylbutyric acid derivatives as matrix metallopr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-biarylbutyric acid derivatives as matrix metallopr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247098